Liang Cheng

Liang Cheng

Auto-generated profile, based on publicly available information

Liang Cheng

Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LCLiang Cheng
Liang Cheng
BYBin Yan
Bin Yan
KCKe Chen
Ke Chen
ZJZhengdong Jiang
Zhengdong Jiang
CZCancan Zhou
Cancan Zhou
HSHuanchen Sha
Huanchen Sha
NAF‐1 (nutrient‐deprivation autophagy factor‐1), which is an outer mitochondrial membrane protein, is known to play important roles in calcium metabolism, antiapoptosis, and antiautophagy. Resveratrol, a natural polyphenolic compound, is considered as a potent anticancer agent. Nevertheless, the molecular mechanisms underlying the effects of resveratrol and NAF‐1 and their mediation of drug resistance in pancreatic cancer remain unclear. Here, we demonstrate that resveratrol suppresses the expression of NAF‐1 in pancreatic cancer cells by inducing cellular reactive oxygen species (ROS) accumulation and activating Nrf2 signaling. In addition, the knockdown of NAF‐1 activates apoptosis and impedes the proliferation of pancreatic cancer cells. More importantly, the targeting of NAF‐1 by resveratrol can improve the sensitivity of pancreatic cancer cells to gemcitabine. These results highlight the significance of strategies that target NAF‐1, which may enhance the efficacy of gemcitabine in pancreatic cancer therapy.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
BYBin Yan
Bin Yan
LCLiang Cheng
Liang Cheng
ZJZhengdong Jiang
Zhengdong Jiang
KCKe Chen
Ke Chen
CZCancan Zhou
Cancan Zhou
JMjiguang ma
jiguang ma
Activation of pancreatic stellate cells (PSCs) initiates pancreatic fibrosis in chronic pancreatitis and furnishes a niche that enhances the malignancy of pancreatic cancer cells (PCCs) in pancreatic ductal adenocarcinoma (PDAC). Resveratrol (RSV), a natural polyphenol, exhibits potent antioxidant and anticancer effects. However, whether and how RSV influences the biological properties of activated PSCs and the effects of these changes on tumor remain unknown. In the present study, we found that RSV impeded hydrogen peroxide‐driven reactive oxygen species‐ (ROS‐) induced activation, invasion, migration, and glycolysis of PSCs. In addition, miR‐21 expression in activated PSCs was downregulated after RSV treatment, whereas the PTEN protein level increased. miR‐21 silencing attenuated ROS‐induced activation, invasion, migration, and glycolysis of PSCs, whereas the overexpression of miR‐21 rescued the responses of PSCs treated with RSV. Moreover, RSV or N‐acetyl‐L‐cysteine (NAC) administration or miR‐21 knockdown in PSCs reduced the invasion and migration of PCCs in coculture, and the effects of RSV were partly reversed by miR‐21 upregulation. Collectively, RSV inhibits PCC invasion and migration through suppression of ROS/miR‐21‐mediated activation and glycolysis in PSCs. Therefore, targeting miR‐21‐mediated glycolysis by RSV in tumor stroma may serve as a new strategy for clinical PDAC prevention or treatment.

20 August 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
QXQinhong Xu
Qinhong Xu
YXYing Xiao
Ying Xiao
XLXuqi Li
Xuqi Li
LFLin Fan
Lin Fan
CZCancan Zhou
Cancan Zhou
GWGuang-Hui Wang
Guang-Hui Wang
Background: Gastric Cancer (GC) is one of the most malignant and lethal tumors worldwide. The hypoxic microenvironment is correlated with GC cell invasion, metastasis and Epithelial-Mesenchymal Transition (EMT). Resveratrol is a compound extracted from various plants, including grapes, berries, and some traditional Chinese medicines. Recently, the anticancer properties of resveratrol against many cancers have been reported in a range of studies. However, the exact mechanism through which resveratrol prevents GC invasion and metastasis under hypoxic conditions remains unclear. Objective: The objective of this study is to show to what extent resveratrol could inhibit the hypoxia-induced malignant biological behavior of GC. Methods: SGC-7901 cells were cultured in a consistent 3% O2 hypoxic condition or 21% O2 normal condition for 48 hours to establish an in vitro hypoxia model. Western blot and qRT-PCR were used to detect EMT markers of SGC- 7901 cells, including E-cadherin, HIF-1a, Vimentin, etc. Transwell Matrigel Invasion Assays were used to test the invasive ability of SGC-7901 cells. The siRNA targeting Gli-1 showed its role in hypoxia-induced EMT and invasion of SGC-7901 cells. Results: Resveratrol was found to significantly decrease HIF-1α protein levels induced by hypoxia in SGC-7901 cells. HIF-1α accumulation was found to promote cell proliferation, migration, and invasive capacities in addition to EMT changes through the activation of the Hedgehog pathway. These effects were found to be reversed by resveratrol. Conclusion: Therefore, these data indicate that resveratrol may serve as a potential anticancer agent for the treatment of GC, even in a hypoxic tumor microenvironment.

14 September 2016 in Oncology Research
Verified
Journal Article
Open access
YLYAZHOU LI
YAZHOU LI
LYLiu Yang
Liu Yang
FSFeiyu Shi
Feiyu Shi
LCLiang Cheng
Liang Cheng
JSJunjun She
Junjun She
Gastric cancer (GC) is the fourth most common malignancy and the second leading cause of cancer mortality around the world. However, the regulatory mechanisms of GC tumorigenesis and cancer cell motility are completely unknown. We investigated the role of a RAS-related protein (Rap1b) in the progression of GC. Our results showed that the expression of Rap1b is aberrantly upregulated in GC tissue samples and human GC cell lines, and the high expression of Rap1b indicated a positive correlation with poor prognosis in patients with GC. Inhibition of endogenous Rap1b dramatically reduced the cell cycle progression but strongly enhanced the apoptosis capacity of human GC cell lines MKN-28 and SGC-7901 cells compared with the control group. Western blotting assay showed that Rap1b inhibition resulted in a significant increase in the ratio of LC3-II to LC3-I, and the levels of p62 protein were decreased in both MKN-28 and SGC-7901 cells. Furthermore, PI3K/Akt/mTOR activation was found to be maintained in a low level in the normal gastric mucosal epithelial cells, while it was significantly upregulated in GC cells, which could be decreased by Rap1b inhibition. The PI3K inhibitor LY294002 was enhanced but activator insulin-like growth factor 1 (IGF-1) blocked the Rap1b silencing-induced enhancement of apoptosis and autophagy in MKN-28 and SGC-7901 cells. In conclusion, we demonstrate that Rap1b expression is aberrantly increased in GC, resulting in the inhibition of autophagy and apoptosis of GC cells by the PI3K/Akt/mTOR pathway. This might provide a new understanding and represent a novel therapeutic target for human GC.

2 December 2019 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LCLiang Cheng
Liang Cheng
TQTao Qin
Tao Qin
JMJiguang Ma
Jiguang Ma
WDWanxing Duan
Wanxing Duan
QXQinhong Xu
Qinhong Xu
JLJianjun Lei
Jianjun Lei
Background: Recent studies have suggested that 85% of pancreatic cancer patients accompanied with impaired glucose tolerance or even Diabetes Mellitus (DM) and the invasive and migratory abilities of pancreatic cancer could be enhanced by high glucose. This study aimed to investigate whether Hypoxia- Inducible Factor-1α (HIF-1α) mediates hyperglycemia-induced pancreatic cancer glycolysis. Methods: The cellular glycolytic activity was assessed by determining lactate production, glucose uptake and lactate dehydrogenase enzymatic activity. Pancreatic cancer cells (BxPC-3 cells) were transfected with short hairpin RNA targeting the HIF-1α. Results: Hyperglycemia promotes pancreatic cancer glycolysis. Lactate dehydrogenase A (LDHA) activity and hexokinase 2 (HK2), platelet-type of phosphofructokinase (PFKP) expression were significantly upregulated under hyperglycemic conditions. HIF-1α knockdown prominently down-regulated the activity of LDHA and the expression of HK2, PFKP and decreased lactate production in BxPC-3 cells. Under hypoxia condition, hyperglycemia induced pancreatic glycolysis by mechanisms that are both dependent on HIF-1α and independent of it. Conclusion: The accumulation of HIF-1α induced by hyperglycemia increases LDHA activity and HK2, PFKP expression, thereby promoting pancreatic glycolysis to facilitate cancer progression.

22 September 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
HYHuaixi Yu
Huaixi Yu
YLYunyun Li
Yunyun Li
JTJinshan Tang
Jinshan Tang
XLXiaoqing Lu
Xiaoqing Lu
WHWen Hu
Wen Hu
LCLiang Cheng
Liang Cheng
The objective of the present study was to determine the role of RP11‑84C13.1 in osteoporosis (OP) and its molecular mechanism. First, clinical samples were collected from OP patients and normal control patients. Human bone marrow stromal cells (hBMSCs) were extracted from femoral head tissues. Runt‑related transcription factor 2 (RUNX2) and RP11‑84C13.1 serum levels were assessed by reverse transcription‑quantitative (RT‑q)PCR. Following transfection of pcDNA‑RP11‑84C13.1, si‑RP11‑84C13.1, microRNA (miRNA)‑23b‑3p mimic and miRNA‑23b‑3p inhibitor, the expression levels of RUNX2 and RP11‑84C13.1 were determined by RT‑qPCR. In addition, the osteogenic ability of hBMSCs was assessed by Alizarin Red staining. The binding of RP11‑84C13.1 to miRNA‑23b‑3p and the binding of miRNA‑23b‑3p to RUNX2 was confirmed by dual‑luciferase reporter gene assay. Long non‑coding RNA (lncRNA) RP11‑84C13.1 was significantly downregulated in the serum of OP patients. The osteogenic differentiation‑related genes RUNX2 and RP11‑84C13.1 were markedly upregulated in a time‑dependent manner, while the miRNA‑23b‑3p level gradually decreased in hBMSCs with the prolongation of osteogenesis. RP11‑84C13.1 knockdown inhibited the osteogenic differentiation of hBMSCs. Furthermore, RP11‑84C13.1 regulated RUNX2 expression by targeting miRNA‑23b‑3p. Overexpression of miRNA‑23b‑3p partially reversed the promoting effect of RP11‑84C13.1 on the osteogenesis of hBMSCs. In conclusion, lncRNA RP11‑84C13.1 upregulated RUNX2 by absorbing miRNA‑23b‑3p, and thus induced hBMSC osteogenesis to alleviate osteoporosis.